Clinical Trial

A Study of RAY1225 in Participants With Impaired Liver Function

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated March 19, 2025 (before its estimated October 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to assess how fast RAY1225 gets into the blood stream and how long it takes the body to remove it in participants with impaired liver function compared to healthy participants.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-08-27; most recent amendment 2025-03-18.
Trial Details
NCT Number NCT06577415
Lead Sponsor Guangdong Raynovent Biotech Co., Ltd
Conditions Hepatic Impairment
Enrollment 24 participants
Start Date 2024-08-26
Primary Completion 2025-10-31 (estimated)
Study Completion 2025-11-15 (estimated)
Updated on ClinicalTrials.gov 2025-03-19